Latest Articles
Endometriosis Pipeline 2024: Detailed Clinical Trials - openPR
Endometriosis Pipeline 2024: Detailed Clinical Trials openPR
Published: Jan. 16, 2025, 6:40 p.m.
Ananda set for heightened industry interest as clinical trials advance - broker - Proactive Investors UK
Ananda set for heightened industry interest as clinical trials advance - broker Proactive Investors UK
Published: Nov. 22, 2024, 1 p.m.
Lisata Therapeutics CEO David Mazzo on Q3 results; updates on key clinical trials and partnerships - Proactive Investors UK
Lisata Therapeutics CEO David Mazzo on Q3 results; updates on key clinical trials and partnerships Proactive Investors UK
Published: Nov. 14, 2024, 4:39 p.m.
Rubraca sheds positive light for PARP inhibitors in endometrial cancer - Clinical Trials Arena
Rubraca sheds positive light for PARP inhibitors in endometrial cancer Clinical Trials Arena
Published: April 2, 2024, 7 a.m.
Link copied to clipboard!